Clinical Trial Update: Characterization of the Toll-like Receptor 7-agonist Imiquimod 3.75% As a New Surrogate Model of Itch [NA]

View source ↗

Summary

A clinical trial evaluating imiquimod 3.75% as a surrogate model for pruritus (itch) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pruritus

Drugs mentioned

• Imiquimod 3.75% (imiquimod)

Snippet

Sponsor: Aalborg University | Conditions: Itch | NA | Status: WITHDRAWN